Dental Care Clinics in Peapack, NJ Accepting Medicare
1 Dental Care Clinics found. Showing 1 - 1
 Matheny Medical And Educational Center Dentist Medicare: Not Enrolled in Medicare Practice Location: 1467 Highland Avenue, Peapack, NJ 07977 Phone: 908-234-0011 Fax: 908-234-9496 |
News Archive
Unknown 'root' extension in hair cells of the inner ear
The hair cells of the inner ear have a previously unknown "root" extension that may allow them to communicate with nerve cells and the brain to regulate sensitivity to sound vibrations and head position, researchers at the University of Illinois at Chicago College of Medicine have discovered. Their finding is reported online in advance of print in the Proceedings of the National Academy of Sciences.
Aspect and Bruker BioSpin collaborate to develop a new high performance desktop preclinical MRI system
At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Aspect Magnet Technologies and Bruker BioSpin, a division of Bruker Corporation (NASDAQ: BRKR), today announced that they have signed a Memorandum of Understanding (MoU) for the development of a high performance desktop preclinical MRI system.
Increasing specific microRNA levels can restore chemotherapy sensitivity in pancreatic cancer cells
By increasing the level of a specific microRNA (miRNA) molecule, researchers have for the first time restored chemotherapy sensitivity in vitro to a line of human pancreatic cancer cells that had developed resistance to a common treatment drug.
Fear of cancer spurs breast implant recall
There are concerns regarding breast implants and the association with cancer. UP to 30,000 French women and perhaps tens of thousands more around the world may need to have defective breast implants removed after several suspicious cancer cases. The final decision on recall of the implants, produced by the Poly Implant Prothese (PIP) company will be made by the end of the week, after a report from France's National Cancer Institute on December 23.
Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte
Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company's proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).
› Verified 3 days ago